HK1044169A1 - Vascular adhesion molecules and modulation of their function - Google Patents

Vascular adhesion molecules and modulation of their function

Info

Publication number
HK1044169A1
HK1044169A1 HK02104558.4A HK02104558A HK1044169A1 HK 1044169 A1 HK1044169 A1 HK 1044169A1 HK 02104558 A HK02104558 A HK 02104558A HK 1044169 A1 HK1044169 A1 HK 1044169A1
Authority
HK
Hong Kong
Prior art keywords
adhesion molecules
modulation
function
vascular adhesion
cram
Prior art date
Application number
HK02104558.4A
Other languages
English (en)
Inventor
Beat Albert Imhof
Michel Aurrand-Lions
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of HK1044169A1 publication Critical patent/HK1044169A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK02104558.4A 1999-03-11 2002-06-19 Vascular adhesion molecules and modulation of their function HK1044169A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99200746 1999-03-11
PCT/EP2000/002219 WO2000053749A2 (fr) 1999-03-11 2000-03-13 Molecules d'adhesion vasculaire et modulation de leur fonction

Publications (1)

Publication Number Publication Date
HK1044169A1 true HK1044169A1 (en) 2002-10-11

Family

ID=8239973

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104558.4A HK1044169A1 (en) 1999-03-11 2002-06-19 Vascular adhesion molecules and modulation of their function

Country Status (23)

Country Link
US (3) US7393651B2 (fr)
EP (2) EP2292761A1 (fr)
JP (2) JP4836329B2 (fr)
CN (2) CN1637019A (fr)
AT (1) ATE500328T1 (fr)
AU (1) AU782139B2 (fr)
BR (1) BR0008915A (fr)
CA (1) CA2362896C (fr)
CZ (1) CZ303128B6 (fr)
DE (1) DE60045681D1 (fr)
EE (1) EE05497B1 (fr)
ES (1) ES2361905T3 (fr)
HK (1) HK1044169A1 (fr)
HU (1) HU229376B1 (fr)
IL (1) IL145310A0 (fr)
IS (1) IS2819B (fr)
MX (1) MXPA01009110A (fr)
NO (1) NO333085B1 (fr)
NZ (1) NZ514091A (fr)
PL (1) PL207994B1 (fr)
RU (1) RU2244748C2 (fr)
WO (1) WO2000053749A2 (fr)
ZA (1) ZA200107283B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088386B2 (en) 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
US8007798B2 (en) 1997-11-21 2011-08-30 Genentech, Inc. Treatment of complement-associated disorders
CN1637019A (zh) * 1999-03-11 2005-07-13 Rmf迪克塔吉恩有限公司 血管粘着分子及其功能的调节
GB0100750D0 (en) * 2001-01-11 2001-02-21 Inpharmatica Ltd Novel proteins
WO2003006673A2 (fr) * 2001-07-11 2003-01-23 Texas Biotechnology Corporation Acide nucleique codant une proteine d'adhesion jonctionnelle humaine (jam3)
US7642341B2 (en) 2003-12-18 2010-01-05 Merck Serono S.A. Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer
EP1533617A1 (fr) * 2003-11-19 2005-05-25 RMF Dictagene S.A. Molécules inhibant l'angiogénèse, leur sélection, production et utilisation pour le traitement et diagnose du cancer
NZ594285A (en) 2005-11-04 2013-02-22 Genentech Inc USE OF COMPLEMENT PATHWAY INHIBITOR ANTIBODY AGAINST C5a TO TREAT OCULAR DISEASES
RU2464030C2 (ru) * 2006-05-26 2012-10-20 Регадо Байосайенсиз, Инк. Введение противосвертывающей системы reg1
CA2663243A1 (fr) 2006-09-28 2008-04-03 Merck Serono S.A. Composes se liant aux molecules d'adherence jonctionnelles c (jam-c) et procedes d'utilisation correspondants
KR20160092061A (ko) 2006-11-02 2016-08-03 제넨테크, 인크. 인간화 항-ｄ 인자 항체
FR2909092B1 (fr) * 2006-11-24 2012-10-19 Pf Medicament Nouveaux anticorps anti-proliferation
AR066660A1 (es) 2007-05-23 2009-09-02 Genentech Inc Prevencion y tratamiento de condiciones del ojo asociadas con su complemento
BRPI0815094B8 (pt) * 2007-08-06 2023-04-18 Noxxon Pharma Ag Uso de uma molécula de ácido l-nucleico ligada a sdf-1
CR20170001A (es) 2008-04-28 2017-08-10 Genentech Inc Anticuerpos anti factor d humanizados
CR20160132A (es) 2013-08-12 2016-08-25 Genentech Inc Composiciones y método para tratar condiciones asociadas con el complemento
MX2016014160A (es) 2014-05-01 2017-02-16 Genentech Inc Variantes del anticuerpo anti-factor d y sus usos.
WO2017075252A1 (fr) 2015-10-30 2017-05-04 Genentech, Inc. Conjugués de variants d'anticorps anti-facteur d et leurs utilisations
JP2018534930A (ja) 2015-10-30 2018-11-29 ジェネンテック， インコーポレイテッド 抗ｄ因子抗体及びコンジュゲート

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000053753A2 (fr) * 1999-03-08 2000-09-14 Genentech, Inc. Activation ou inhibition de l'angiogenese et de la cardiovascularisation
US20030170864A1 (en) * 2000-05-30 2003-09-11 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
SE9604470D0 (sv) * 1996-12-04 1996-12-04 Tamas Bartfai Konsulting Ab Transmembrane component of tight junction
CA2283678A1 (fr) * 1997-03-14 1998-09-17 Human Genome Sciences, Inc. 28 proteines secretees par l'homme
EP0970111A2 (fr) * 1997-03-21 2000-01-12 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
JP2001512014A (ja) 1997-08-01 2001-08-21 ジェンセット 脳組織から同定された分泌タンパク質の５’ｅｓｔ
US20030082540A1 (en) 1997-09-17 2003-05-01 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1002864A1 (fr) 1998-11-10 2000-05-24 Universita' degli studi di Bologna HIgR et domaine V relié pour la préparation d'un médicament pour la prévention et le traitement des infections de HSV-1, HSV-2 et BHV
MXPA01006057A (es) * 1998-12-16 2003-09-10 Genentech Inc Polipeptidos secretados y transmembranales y acidos nucleicos que los codifican.
CN1637019A (zh) * 1999-03-11 2005-07-13 Rmf迪克塔吉恩有限公司 血管粘着分子及其功能的调节
US7642341B2 (en) 2003-12-18 2010-01-05 Merck Serono S.A. Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer
EP1533617A1 (fr) 2003-11-19 2005-05-25 RMF Dictagene S.A. Molécules inhibant l'angiogénèse, leur sélection, production et utilisation pour le traitement et diagnose du cancer

Also Published As

Publication number Publication date
JP2002537837A (ja) 2002-11-12
CN1355843A (zh) 2002-06-26
US7393651B2 (en) 2008-07-01
AU782139B2 (en) 2005-07-07
EE200100472A (et) 2002-12-16
BR0008915A (pt) 2002-04-09
US7670826B2 (en) 2010-03-02
ZA200107283B (en) 2002-12-24
CN100469878C (zh) 2009-03-18
EP2292761A1 (fr) 2011-03-09
AU4105100A (en) 2000-09-28
WO2000053749A3 (fr) 2000-12-14
CN1637019A (zh) 2005-07-13
RU2244748C2 (ru) 2005-01-20
US20050266426A1 (en) 2005-12-01
US20100267649A1 (en) 2010-10-21
EP1163337B1 (fr) 2011-03-02
IL145310A0 (en) 2003-01-12
NO333085B1 (no) 2013-02-25
JP4836329B2 (ja) 2011-12-14
IS2819B (is) 2012-12-15
HU229376B1 (en) 2013-11-28
NO20014417L (no) 2001-11-12
NZ514091A (en) 2004-01-30
WO2000053749A2 (fr) 2000-09-14
ATE500328T1 (de) 2011-03-15
CZ20013267A3 (cs) 2002-02-13
PL207994B1 (pl) 2011-02-28
NO20014417D0 (no) 2001-09-11
EP1163337A2 (fr) 2001-12-19
CA2362896A1 (fr) 2000-09-14
HUP0200606A3 (en) 2004-11-29
CZ303128B6 (cs) 2012-04-18
US8143056B2 (en) 2012-03-27
MXPA01009110A (es) 2002-08-20
PL350417A1 (en) 2002-12-16
IS6072A (is) 2001-09-10
EE05497B1 (et) 2011-12-15
US20080274970A1 (en) 2008-11-06
CA2362896C (fr) 2012-07-31
JP2010233572A (ja) 2010-10-21
ES2361905T3 (es) 2011-06-24
HUP0200606A2 (en) 2002-06-29
DE60045681D1 (de) 2011-04-14

Similar Documents

Publication Publication Date Title
HK1044169A1 (en) Vascular adhesion molecules and modulation of their function
DE69731373D1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
MXPA02001911A (es) Anticuerpos ctla-4 humanos y sus usos.
SI1132403T1 (sl) Peptidi inhibitorji tgf-g beta 1
DE69427650D1 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
DE60331546D1 (de) Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung
HUT66309A (en) Bpc peptides, their preparation and therapeutic use
DK0770089T3 (da) Vækstdifferentieringsfaktor-12
BR9007115A (pt) Novo trombolitico
EP0816504A3 (fr) Facteur d'activation des plaquettes acétylhydrolase, et gène codant celui-ci
DE69832197D1 (de) Rantes mutanten und deren therapeutische verwendungen
PT870036E (pt) Α-n-acetilglucosaminidase de mamífero sintética e sequências genéticas codificando a mesma
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
AU5327198A (en) Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
BG105682A (en) Bone stimulating factor
WO1999030670A3 (fr) Procedes de traitement utilisant de nouveaux ligands du recepteur hfgan72 de neuropeptides et leurs agonistes ou antagonistes
EP0832109A4 (fr) Facteur-2 homologue du facteur de croissance des fibroplastes et procedes d'utilisation
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
WO1999046381A3 (fr) Gene du fgf humain et produit d'expression genique

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180313